Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest
- 30 June 1993
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 55 (6), 1418-1424
- https://doi.org/10.1016/0003-4975(93)91082-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Aprotinin in perspectiveThe Annals of Thoracic Surgery, 1993
- Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled studyThe Annals of Thoracic Surgery, 1992
- Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypassThe Annals of Thoracic Surgery, 1991
- Aprotinin (Trasylol) is a competitive inhibitor of activated protein CThrombosis Research, 1989
- Pharmacology of Aprotinin and Efficacy During Cardiopulmonary BypassCardiovascular Drug Reviews, 1989
- Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1987
- APROTININ (TRASYLOL) PROTECTION-UNSUITABLE FOR HYPOTHERMIC KIDNEY PRESERVATIONTransplantation, 1984
- Hochdosierte Aprotinin (Trasylol)-Therapie —unschädlich für die Niere?Langenbecks Archives Of Surgery, 1983
- The neutralisation of heparin by trasylolThrombosis Research, 1980
- TRASYLOL (APROTININ) AND KIDNEY PRESERVATIONTransplantation, 1978